FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
110.000 |
Evidence |
O
|
SPINK1 |
SPINK1, PSTI: Pancreatic secretory trypsin inhibitor precursor |
CPB1 |
CPB1, CPB, PCPB: Carboxypeptidase B precursor |
110.000 |
Evidence |
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
110.000 |
Evidence |
|
ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
PON1 |
IPI00555746 |
110.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
109.000 |
Evidence |
|
GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
109.000 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
109.000 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
109.000 |
Evidence |
|
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
109.000 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
109.000 |
Evidence |
|
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
CSPG2 |
IPI00009802 |
109.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
109.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
109.000 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
109.000 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
LYN |
LYN: Tyrosine-protein kinase Lyn |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
109.000 |
Evidence |
|
PRKDC |
PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
109.000 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
109.000 |
Evidence |
|
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CCNB1 |
Cyclin B1 |
109.000 |
Evidence |
|
STXBP2 |
STXBP2, UNC18B: Syntaxin-binding protein 2 |
STX1A |
STX1A, STX1: Syntaxin-1A |
109.000 |
Evidence |
|